ADPT – Adaptive Biotechnologies Corporation
Adaptive Biotechnologies CorporADPT
$6.81Name : Adaptive Biotechnologies Corpor
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $1,005,013,056.00
EPSttm : -1.34
Adaptive Biotechnologies Corpor
$6.81
1.59%$0.11Float Short %
6.44
Margin Of Safety %
Put/Call OI Ratio
0.23
EPS Next Q Diff
-0.05
EPS Last/This Y
0.45
EPS This/Next Y
0.25
Price
6.82
Target Price
7.58
Analyst Recom
1.5
Performance Q
41.87
Relative Volume
0.82
Beta
1.47
Ticker: ADPT
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | ADPT | 5.99 | 0.32 | 0.01 | 1459 |
| 2024-12-20 | ADPT | 6.41 | 0.28 | 0.95 | 1619 |
| 2024-12-23 | ADPT | 6.31 | 0.33 | 0.50 | 1336 |
| 2024-12-24 | ADPT | 6.39 | 0.33 | 0.14 | 1338 |
| 2024-12-26 | ADPT | 6.45 | 0.33 | 0.04 | 1338 |
| 2024-12-27 | ADPT | 6.29 | 0.33 | 0.20 | 1354 |
| 2024-12-30 | ADPT | 6.1 | 0.33 | 0.03 | 1354 |
| 2024-12-31 | ADPT | 5.99 | 0.32 | 13.67 | 1384 |
| 2025-01-02 | ADPT | 6.18 | 0.32 | 0.00 | 1386 |
| 2025-01-03 | ADPT | 7.19 | 0.32 | 0.03 | 1388 |
| 2025-01-06 | ADPT | 7.01 | 0.26 | 0.00 | 1675 |
| 2025-01-07 | ADPT | 7.1 | 0.24 | 0.00 | 1809 |
| 2025-01-08 | ADPT | 6.69 | 0.22 | 1.00 | 1920 |
| 2025-01-09 | ADPT | 6.69 | 0.22 | 0.17 | 1920 |
| 2025-01-10 | ADPT | 6.49 | 0.22 | 0.20 | 1922 |
| 2025-01-13 | ADPT | 6.45 | 0.22 | 0.06 | 1910 |
| 2025-01-14 | ADPT | 6.07 | 0.21 | 0.40 | 2013 |
| 2025-01-15 | ADPT | 7.15 | 0.22 | 0.00 | 2019 |
| 2025-01-16 | ADPT | 6.95 | 0.22 | 0.79 | 2028 |
| 2025-01-17 | ADPT | 6.81 | 0.23 | 0.03 | 2062 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | ADPT | 6.01 | 19.9 | - | -1.11 |
| 2024-12-20 | ADPT | 6.41 | 19.9 | - | -1.11 |
| 2024-12-23 | ADPT | 6.32 | 19.9 | - | -1.11 |
| 2024-12-24 | ADPT | 6.39 | 19.9 | - | -1.11 |
| 2024-12-26 | ADPT | 6.44 | 19.9 | - | -1.11 |
| 2024-12-27 | ADPT | 6.30 | 19.9 | - | -1.11 |
| 2024-12-30 | ADPT | 6.11 | 19.9 | - | -1.11 |
| 2024-12-31 | ADPT | 5.99 | 19.9 | - | -1.11 |
| 2025-01-02 | ADPT | 6.18 | 19.9 | - | -1.11 |
| 2025-01-03 | ADPT | 7.19 | 19.9 | - | -1.11 |
| 2025-01-06 | ADPT | 7.05 | 19.9 | - | -1.11 |
| 2025-01-07 | ADPT | 7.11 | 19.9 | - | -1.11 |
| 2025-01-08 | ADPT | 6.69 | 19.9 | - | -1.11 |
| 2025-01-09 | ADPT | 6.69 | 19.9 | - | -1.11 |
| 2025-01-10 | ADPT | 6.49 | 19.9 | - | -1.11 |
| 2025-01-13 | ADPT | 6.45 | 19.9 | - | -1.11 |
| 2025-01-14 | ADPT | 6.07 | 19.9 | - | -1.11 |
| 2025-01-15 | ADPT | 7.16 | 19.9 | - | -1.11 |
| 2025-01-16 | ADPT | 6.95 | 19.9 | - | -1.11 |
| 2025-01-17 | ADPT | 6.82 | 19.9 | - | -1.11 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | ADPT | -0.56 | 1.74 | 6.71 |
| 2024-12-20 | ADPT | -0.56 | 1.74 | 6.71 |
| 2024-12-23 | ADPT | -0.52 | 1.67 | 6.71 |
| 2024-12-24 | ADPT | -0.52 | 1.67 | 6.71 |
| 2024-12-26 | ADPT | -0.55 | 1.67 | 6.33 |
| 2024-12-27 | ADPT | -0.56 | 1.67 | 6.33 |
| 2024-12-30 | ADPT | -0.57 | 1.63 | 6.33 |
| 2024-12-31 | ADPT | -0.57 | 1.63 | 6.33 |
| 2025-01-02 | ADPT | -0.57 | 1.63 | 6.33 |
| 2025-01-03 | ADPT | -0.56 | 1.63 | 6.33 |
| 2025-01-06 | ADPT | -0.48 | 1.67 | 6.33 |
| 2025-01-07 | ADPT | -0.48 | 1.67 | 6.33 |
| 2025-01-08 | ADPT | -0.56 | 1.67 | 6.33 |
| 2025-01-09 | ADPT | -0.56 | 1.67 | 6.33 |
| 2025-01-10 | ADPT | -0.56 | 1.67 | 6.33 |
| 2025-01-13 | ADPT | -0.56 | 1.68 | 6.44 |
| 2025-01-14 | ADPT | -0.56 | 1.68 | 6.44 |
| 2025-01-15 | ADPT | -0.56 | 1.68 | 6.44 |
| 2025-01-16 | ADPT | -0.56 | 1.68 | 6.44 |
| 2025-01-17 | ADPT | -0.56 | 1.68 | 6.44 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.22
Avg. EPS Est. Current Quarter
-0.24
Avg. EPS Est. Next Quarter
-0.27
Insider Transactions
-0.56
Institutional Transactions
1.68
Beta
1.47
Average Sales Estimate Current Quarter
45
Average Sales Estimate Next Quarter
46
Fair Value
Quality Score
37
Growth Score
45
Sentiment Score
98
Actual DrawDown %
90.4
Max Drawdown 5-Year %
-96.6
Target Price
7.58
P/E
Forward P/E
PEG
P/S
5.67
P/B
4.49
P/Free Cash Flow
EPS
-1.34
Average EPS Est. Cur. Y
-1.11
EPS Next Y. (Est.)
-0.86
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-110.13
Relative Volume
0.82
Return on Equity vs Sector %
-106.3
Return on Equity vs Industry %
-93.7
EPS 1 7Days Diff
EPS 1 30Days Diff
0.11
EBIT Estimation
Adaptive Biotechnologies CorporSector: Healthcare
Industry: Biotechnology
Employees: 709
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
stock quote shares ADPT – Adaptive Biotechnologies Corporation Stock Price stock today
news today ADPT – Adaptive Biotechnologies Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch ADPT – Adaptive Biotechnologies Corporation yahoo finance google finance
stock history ADPT – Adaptive Biotechnologies Corporation invest stock market
stock prices ADPT premarket after hours
ticker ADPT fair value insiders trading